NVX-412, a New Oncology Drug Candidate, Induces S-Phase Arrest and DNA Damage in Cancer Cells in a p53-Independent Manner

Alexandra Hebar(Medical University of Vienna), Edgar Selzer(Vienna General Hospital)
PLoS ONE
September 13, 2012
Cited by 4


Related Papers